Product Fact Sheet

Btech Eye

The first 3-in-1 eye formula (lutein, zeaxanthin, meso-zeaxanthin) in Malaysia market which uses XanMax®. It plays a major role in protecting retina and retinal pigment epithelium from light-initiated oxidative damage by scavenging reactive oxygen species and filtering blue light, which is involved in the putative pathogenesis of many age-related eye diseases.

Each vegetable capsule (480mg) contains:

Marigold Flower Extract (Tagetes erecta, flos)
standardised to 10% lutein and
2% trans-meso zeaxanthin

200mg

Grape Seed Extract (Vitis vinifera) 100mg

100mg

providing 95% proanthocyanidins

Directions:

Adults – Take 1 capsule, once daily, after a meal or as
recommended by a doctor or pharmacist.

Why Choose VitaHealth Btech Eye?

Improves macular pigment optical density (MPOD) in 48 weeks for AMD patients – With 20mg lutein and 4mg zeaxanthin & meso zeaxanthin, it is able to increase 34.5% MPOD for AMD patients
Protects from high energy blue light – Lutein, zeaxanthin, meso-zeaxanthin could protect the photoreceptor outer segment and the retinal pigment epithelium by screening susceptible retinal structures from blue light
5:1 golden ratio formula of lutein and zeaxanthin according to AREDS2 studies whereby it will not induce lung cancer incidence in large population
Vegetarian-friendly and halal-applicable product – Uses vegetable capsule
Antioxidants for the eyes with conjugated double bond in structure of lutein, zeaxanthin and meso-zeaxanthin, it is ready to accept free radicals; hence, providing anti-oxidation protection to the eyes
Suitable for heavy digital device users (more than 6 hours daily) Supplemental with lutein, zeaxanthin and meso-zeaxanthin restore macular pigment optical density that helps filter blue light emitted from the screens of digital devices
Beneficial to those with early AMD – Antioxidants play a vital role to provide protection against UV and blue light damage causes photo-oxidation reaction and in turn age-related ocular diseases such as AMD
New 20-20-20-20 rules – Looking at something 20 feet away every 20 minutes for 20 seconds and taking supplement loaded with 20mg of lutein
Global AMD raising by 170% − Global prevalence of AMD patients was expected to raise to 288 million by the year 2040 compared to 170 million in 2016
Halal-certified

Benefits

Marigold Flower (Tagetes erecta L.)

Possesses antimicrobial, anti-inflammatory, antioxidant and wound healing properties
Source of carotenoids, lutein and zeaxanthin – nutritional supplements (specially for the eye)

Target Customers

Heavy digital device users
Individuals with early stage AMD
Individuals who have low macular pigment optical density (MPOD)
Individuals who wish to protect macular from blue light damage
Individuals who wish to enhance visual function and comfort
Individuals who see light scattered

References :

Bernstein, P. S., Li, B., Vachali, P. P., Gorusupudi, A., Shyam, R., Henriksen, B. S., & Nolan, J. M. (2016). Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Progress in Retinal and Eye Research, 50, 34-66. doi:10.1016/j.preteyeres.2015.10.003
Blue Light Exposed. Retrieved from http://www.bluelightexposed.com/#blue-light-and-macular degeneration
Gupta, P. (2014). Carotenoids of Therapeutic Significance from Marigold. Natural Products Chemistry & Research, 2(6). doi:10.4172/2329-6836.1000e110
Hammond, B. R., Feltcher, L. M., & Elliott, J. G. (2013). Glare Diability, Photostress Recovery, and Chromatic Contrast: Relation to Macular Pigment and Serum Lutein and Zeaxanthin Macular Pigment and Visual Function. Ingestigative ophthalmology & visual science, 54(1), 476-481.
Huang, Y., Dou, H., Huang, F., Xu, X., Zou, Z., Lu, X., & Lin, X. (2014). Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial. British Journal of Ophthalmology, 99(3), 371-375. doi:10.1136/bjophthalmol-2014-305503
Koushan K, Rusovici R, Li W, Ferguson LR, Chalam KV. The role of lutein in eye-related disease. Nutrients 2013;5:1823-39.
Pennington, K. L., & DeAngelis, M. M. (2016). Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye and Vision, 3(1). doi:10.1186/s40662-016-0063-5
Protect your vision — Blue Light Exposed. Retrieved from http://www.bluelightexposed.com/protect-our-vision/#who-needs-protection-from-blue-light-exposur e-1-1-1
Scripsema, N. K., Hu, D., & Rosen, R. B. (2015). Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease. Journal of Ophthalmology, 2015, 1-13. doi:10.1155/2015/865179
Walls, H. L., Walls, K. L., & Benke, G. (2011). Eye Disease Resulting From Increased Use of Fluorescent Lighting as a Climate Change Mitigation Strategy. American Journal of Public Health, 101(12),
2222-2225. doi:10.2105/ajph.2011.300246